Rilpivirine Tablets

Product Description

Rilpivirine 25 mg tablets are a medication used in the treatment of HIV infection. Rilpivirine is an antiretroviral medication that belongs to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It works by inhibiting the action of the enzyme reverse transcriptase, which is essential for the replication of the HIV virus. This helps to reduce the viral load in the body and slow down the progression of HIV infection.

Rilpivirine is often used in combination with other antiretroviral drugs as part of a comprehensive HIV treatment regimen known as antiretroviral therapy (ART). This combination therapy is typically tailored to the individual patient based on factors such as their viral load, CD4 cell count, treatment history, and any drug resistance mutations present.

It's important for patients taking rilpivirine tablets to follow their healthcare provider's instructions carefully and to take the medication exactly as prescribed. Skipping doses or not taking the medication consistently can lead to treatment failure and the development of drug-resistant strains of HIV.

Common side effects of rilpivirine may include nausea, headache, dizziness, trouble sleeping, and rash. More serious side effects can occur, so it's essential for patients to report any unusual or severe symptoms to their healthcare provider.

As with any medication, rilpivirine tablets can interact with other drugs, so it's important for patients to inform their healthcare provider about all medications, supplements, and herbal products they are taking before starting rilpivirine therapy.

Overall, rilpivirine is an important component of HIV treatment and has been shown to be effective in helping people with HIV manage their condition and improve their quality of life.

Effective HIV-1 Management

Rilpivirine Tablets offer an essential option for managing HIV-1 infection in eligible patients. Recognized for their effectiveness as part of combination antiretroviral therapy, they help suppress the viral load and slow disease progression. Their once-daily dosing supports patient compliance and enhances overall treatment outcomes.


Quality and Regulatory Assurance

Manufactured in India to stringent WHO and USFDA standards, these tablets undergo rigorous quality checks for safety and efficacy. Their status as a prequalified product by major regulatory agencies ensures global accessibility and trusted performance.